In the context of pancreatic cancer, inhibition of Bruton's tyrosine kinase (BTK) disrupted B‐cell–macrophage interactions, restoring T‐cell responses and sensitising tumours to chemotherapy.112. This evidence concerns the gene BTK and pancreatic neoplasm.